IMPD: chemical & pharmaceutical quality of clinical test preparations and CHMP Guideline

- the quality of clinical test specimens is subject since the entry into force of the new CHMP Guideline on 1 October 2006 risen requirements. This concerns above all the quality in the process of a clinical examination and the documentation obligations for the IMPD.

FORUM Institut for management, one of the prominent seminar offerers of Germany, offers a compact advanced training to interested coworkers of pharmaceutical enterprises for this topic. The intensive seminar takes place to 03.05.2007 in Cologne. Further information to the seminar and to the organizer finds you under: www.forum-institut.de/veranstaltung.aspSemNr=0705235

In the focus of the seminar are located the evaluation of the IMPD of quality part by the federal upper authority, documentation obligations with placebo preparations as well as information to Drug substance, Drug product, to comparison medication, uvm.

Contact:
Dr. Henriette wolf-small
Range chief Pharma
FORUM Institut for management GmbH, Heidelberg
Vangerowstrasse 18
69115 Heidelberg
Tel. 06221 500,680
Fax. 06221 500,618
h.wolf-klein@forum-institut.de

The FORUM Institut for management GmbH stands for 25 years for practice-oriented and founded knowledge transfer in enterprise questions on highest level. FORUM is 100% daughter of Springer Science + Business Media, one the offerer for science and technical literature, leading world-wide. The broadly varied offer covers conferences and conferences to current developments, in addition, seminars and training courses of several days. In the year 2005 more than 30,000 high-level personnel from almost all countries of Europe and from the United States participated on over 1.400 meetings of the institutes for forum.

Dieser Artikel wurde veröffentlicht auf